NICE deems daclizumab cost effective to treat MS patients
Posted: Fri Mar 17, 2017 1:40 am
The National Institute of Health and Care Excellence (NICE) has announced daclizumab as a cost effective treatment for people with relapsing remitting MS (RRMS)...Read more - http://www.ms-uk.org/nice-deems-daclizu ... nts-170317